Table 1.
Patient characteristics (n = 32).
| Characteristics | n = 32 |
|---|---|
| Age, median (range) | 62 (44–81) |
| Sex, n (%) | |
| Male | 21 (65.6) |
| Female | 11 (34.4) |
| Stage (pAJCC)*, n (%) | |
| IA, IB | 1 (3.1) |
| IIA | 9 (28.1) |
| IIB | 17 (53.1) |
| III | 5 (15.6) |
| Name of Operation, n (%) | |
| Pancreatoduodenectomy | 22 (68.8) |
| Distal pancreatectomy | 9 (28.1) |
| Total pancreatectomy | 1 (3.1) |
| Resection margin, n (%) | |
| R0 | 25 (78.1) |
| R1 | 7 (21.9) |
| Adjuvant treatment, n (%) | 28 (87.5) |
| Neoadjuvant treatment, n (%) | 6 (18.8) |
| Total bilirubin, median (range) | 1.0 (0.2–19.2) |
| CA 19-9 (IU/ml), median (range) | 156.6 (2.0–12,000) |
| CEA (ng/ml), median (range) | 2.4 (0.7–51.2) |
CA 19-9, carbohydrate antigen 19-9; CEA, carcinoembryonic antigen.
*pathological stage according to the AJCC.